Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When the 1,000 Genomes Project launched the following ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

San Diego gene sequencing giant Illumina is investing more in artificial intelligence to fuel the company’s growth strategy through a partnership with Nvidia. Nvidia — the Santa Clara tech ...

Meanwhile, it doesn't seem coincidental that Illumina, which is the most significant genetic sequencing business in the world, has a large Chinese rival in biotech BGI Genomics. Ever feel like you ...

Roche, Illumina and Life Technologies ... The current library preparation methods for next-generation sequencing are time-consuming and prone to considerable sample loss. Even before library ...

Work within a regulated sequencing workflow for developing ... in a research environment and use the full range of Illumina sequencing methods for a wide range of applications.

Our proprietary microbial solutions deliver significantly enhanced sensitivity, specificity, and depth when compared to traditional methods ... read (Illumina) 16S-EZ - For genus/species ...